Fischer Medical

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE771F01041
  • NSEID: FISCHER
  • BSEID: 524743
INR
46.10
-0.67 (-1.43%)
BSENSE

Dec 05

BSE+NSE Vol: 7.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Net Sales
109.75
49.78
0.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
109.75
49.78
0.00
Raw Material Cost
0.15
0.00
0.00
Purchase of Finished goods
18.78
58.38
0.00
(Increase) / Decrease In Stocks
6.30
-13.64
0.00
Employee Cost
6.91
0.90
0.00
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
49.17
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
7.93
3.81
0.00
Total Expenditure (Excl Depreciation)
89.24
49.45
0.00
Operating Profit (PBDIT) excl Other Income
20.51
0.33
0.00
Other Income
9.95
0.97
0.00
Operating Profit (PBDIT)
30.46
1.30
0.00
Interest
1.59
0.17
0.00
Exceptional Items
-0.15
-0.26
0.00
Gross Profit (PBDT)
28.72
0.87
0.00
Depreciation
1.28
0.57
0.00
Profit Before Tax
27.44
0.29
0.00
Tax
8.53
0.11
0.00
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.90
0.18
0.00
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
18.90
0.18
0.00
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.90
0.18
0.00
Equity Capital
53.50
53.50
53.50
Face Value
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.53
0.0
0.0
Diluted Earnings per share
2.92
0.0
0.0
Operating Profit Margin (Excl OI)
18.69%
0.66%
0.0%
Gross Profit Margin
26.17%
1.75%
0.0%
PAT Margin
17.22%
0.36%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 120.47% vs 0.00% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 10,400.00% vs 0.00% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 6,115.15% vs 0.00% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 835.29% vs 0.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Fischer Medical With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
109.75
544.44
-434.69
-79.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
109.75
544.44
-434.69
-79.84%
Raw Material Cost
0.15
257.52
-257.37
-99.94%
Purchase of Finished goods
18.78
1.34
17.44
1,301.49%
(Increase) / Decrease In Stocks
6.30
-11.18
17.48
156.35%
Employee Cost
6.91
63.72
-56.81
-89.16%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
49.17
0.00
49.17
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
7.93
137.14
-129.21
-94.22%
Total Expenditure (Excl Depreciation)
89.24
448.54
-359.30
-80.10%
Operating Profit (PBDIT) excl Other Income
20.51
95.90
-75.39
-78.61%
Other Income
9.95
24.07
-14.12
-58.66%
Operating Profit (PBDIT)
30.46
119.97
-89.51
-74.61%
Interest
1.59
0.92
0.67
72.83%
Exceptional Items
-0.15
0.00
-0.15
Gross Profit (PBDT)
28.72
119.05
-90.33
-75.88%
Depreciation
1.28
12.36
-11.08
-89.64%
Profit Before Tax
27.44
106.69
-79.25
-74.28%
Tax
8.53
24.51
-15.98
-65.20%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.90
82.18
-63.28
-77.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
18.90
82.18
-63.28
-77.00%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.90
82.18
-63.28
-77.00%
Equity Capital
53.50
45.34
8.16
18.00%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.53
1.81
1.72
95.03%
Diluted Earnings per share
2.92
1.81
1.11
61.33%
Operating Profit Margin (Excl OI)
18.69%
17.61%
0.00
1.08%
Gross Profit Margin
26.17%
21.87%
0.00
4.30%
PAT Margin
17.22%
15.09%
0.00
2.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 109.75 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 120.47% vs 0.00% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 18.90 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 10,400.00% vs 0.00% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.51 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 6,115.15% vs 0.00% in Sep 2024

Half Yearly - Interest
Interest 1.59 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 835.29% vs 0.00% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.69%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024